Biosensors International’s substantial shareholder CB Medical Holdings has agreed to raise the offer price to 84 cents for each Biosensors share for the proposed amalgamation of the two companies announced on Oct 28 2015.
CB Medical, a subsidiary of CITIC Private Equity Funds Management Co., had originally valued each share of the medical stent manufacturer at 81.5 cents in cash before raising it to 82.5 cents.
Shares of Biosensors last traded at 81.5 cents on Tuesday.
As of Jan 13, Bionsensors has an issued and paid up capital comprising 1.77 billion shares of which 78.7 million are held as treasury shares. This values the deal at about $1.5 billion.
The proposed amalgamation is subject to the approval of shareholders.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
CB Medical, a subsidiary of CITIC Private Equity Funds Management Co., had originally valued each share of the medical stent manufacturer at 81.5 cents in cash before raising it to 82.5 cents.
Shares of Biosensors last traded at 81.5 cents on Tuesday.
As of Jan 13, Bionsensors has an issued and paid up capital comprising 1.77 billion shares of which 78.7 million are held as treasury shares. This values the deal at about $1.5 billion.
The proposed amalgamation is subject to the approval of shareholders.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
No comments:
Post a Comment